TY - JOUR
T1 - Transcriptome and genome sequencing uncovers functional variation in humans
AU - Lappalainen, Tuuli
AU - Sammeth, Michael
AU - Friedländer, Marc R.
AU - 'T Hoen, Peter A.C.
AU - Monlong, Jean
AU - Rivas, Manuel A.
AU - Gonzàlez-Porta, Mar
AU - Kurbatova, Natalja
AU - Griebel, Thasso
AU - Ferreira, Pedro G.
AU - Barann, Matthias
AU - Wieland, Thomas
AU - Greger, Liliana
AU - Van Iterson, Maarten
AU - Almlöf, Jonas
AU - Ribeca, Paolo
AU - Pulyakhina, Irina
AU - Esser, Daniela
AU - Giger, Thomas
AU - Tikhonov, Andrew
AU - Sultan, Marc
AU - Bertier, Gabrielle
AU - Macarthur, Daniel G.
AU - Lek, Monkol
AU - Lizano, Esther
AU - Buermans, Henk P.J.
AU - Padioleau, Ismael
AU - Schwarzmayr, Thomas
AU - Karlberg, Olof
AU - Ongen, Halit
AU - Kilpinen, Helena
AU - Beltran, Sergi
AU - Gut, Marta
AU - Kahlem, Katja
AU - Amstislavskiy, Vyacheslav
AU - Stegle, Oliver
AU - Pirinen, Matti
AU - Montgomery, Stephen B.
AU - Donnelly, Peter
AU - McCarthy, Mark I.
AU - Flicek, Paul
AU - Strom, Tim M.
AU - Lehrach, Hans
AU - Schreiber, Stefan
AU - Sudbrak, Ralf
AU - Carracedo, Ángel
AU - Antonarakis, Stylianos E.
AU - Häsler, Robert
AU - Syvänen, Ann Christine
AU - Van Ommen, Gert Jan
AU - Brazma, Alvis
AU - Meitinger, Thomas
AU - Rosenstiel, Philip
AU - Guigó, Roderic
AU - Gut, Ivo G.
AU - Estivill, Xavier
AU - Dermitzakis, Emmanouil T.
N1 - Funding Information:
Acknowledgements We would like to thank E. Falconnet, L. Romano, A. Planchon, D. Bielsen, A. Yurovsky, A. Buil, J. Bryois, A. Nica, I. Topolsky, N. Fusi, S. Waszak, C. Bustamante, J. Rung, N. Kolesnikov, A. Roa, E. Bragin, S. Brent, J. Gonzalez, M. Morell, A. Puig, E. Palumbo, M. Ventayol Garcia, J. F. J. Laros, J. Blanc, R. Birkelund, G. Plaja, M. Ingham, J. Camps, M. Bayes, L. Agueda, A. Gouin, M.-L. Yaspo, E. Graf, A. Walther, C. Fischer, S. Loesecke, B. Schmick, D. Balzereit, S. Dökel, M. Linser, A. Kovacsovics, M. Friskovec, C. von der Lancken, M. Schlapkohl, A. Hellmann, M. Schilhabel, the SNP&SEQ Technology Platform in Uppsala, S. Sauer, the Vital-IT high-performance computing centreofthe SIBSwiss InstituteofBioinformatics,B.Goldstein andothers at the Coriell Institute, and J. Cooper, E. Burnett, K. Ball and others at the European Collection of Cell Cultures (ECACC) and the 1000 Genomes Consortium. This project was funded by the European Commission 7th Framework Program (FP7) (261123; GEUVADIS); the Swiss National Science Foundation (130326, 130342), the Louis Jeantet Foundation, andERC (260927) (E.T.D.); NIH-NIMH (MH090941) (E.T.D., M.I.M., R.G.); Spanish Plan Nacional SAF2008-00357 (NOVADIS), the Generalitat de Catalunya AGAUR 2009 SGR-1502, and the Instituto de Salud Carlos III (FIS/FEDER PI11/00733) (X.E.); Spanish Plan Nacional (BIO2011-26205) and ERC (294653) (R.G.); ESGI, READNA (FP7 Health-F4-2008-201418), Spanish Ministry of Economy and Competitiveness (MINECO) and the Generalitat de Catalunya (I.G.G.); DFG Cluster of Excellence Inflammation at Interfaces, the INTERREG4A project HIT-ID, and the BMBF IHEC project DEEP SP 2.3 (P.Ro.); German Centre for Cardiovascular Research (DZHK) and the German Ministry of Education and Research (01GR0802, 01GM0867, 01GR0804, 16EX1020C) (T.M.); EurocanPlatform (FP7 260791), ENGAGE and CAGEKID (241669) (A.B.); FP7/2007-2013, ENGAGE project, HEALTH-F4-2007-201413, and the Centre for Medical Systems Biology within the framework of The Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific and Research (NWO) (P.AC.H and G.-J.v.O.); The Swedish Research Council (C0524801, A028001) and the Knut and Alice Wallenberg Foundation (2011.0073) (A.-C.S.); The Swiss National Science Foundation (127375, 144082) and ERC (249968) (S.E.A.); Instituto de Salud Carlos III (FIS/FEDER PS09/02368) (A.C.); German Federal Ministry of Education and Research (01GS08201) (R.S.); Max Planck Society (H.L.); Wellcome Trust (WT085532) and the European Molecular Biology Laboratory (P.F.); ENGAGE, Wellcome Trust (081917, 090367, 090532, 098381), and Medical Research Council UK (G0601261) (M.I.M.); Wellcome Trust Centre for Human Genetics (090532/Z/09/ Z, 075491/Z/04/B), Wellcome Trust (098381, 090367, 076113, 083270), the WTCCC2 project (085475/B/08/Z, 085475/Z/08/Z), Royal Society Wolfson Merit Award, Wellcome Trust Senior Investigator Award (095552/Z/11/Z) (P.D.); EMBO long-term fellowship EMBO-ALTF 2010-337 (H.K.); NIH-NIGMS (R01 GM104371) (D.G.M.); Marie Curie FP7 fellowship (O.S.); Scholarship by the Clarendon Fund of the University of Oxford, and the Nuffield Department of Medicine (M.A.R.); EMBO long-term fellowship ALTF225-2011 (M.R.F.); Emil AaltonenFoundationandAcademy of Finland fellowships (T.L.).
PY - 2013
Y1 - 2013
N2 - Genome sequencing projects are discovering millions of genetic variants in humans, and interpretation of their functional effects is essential for understanding the genetic basis of variation in human traits. Here we report sequencing and deep analysis of messenger RNA and microRNA from lymphoblastoid cell lines of 462 individuals from the 1000 Genomes Project - the first uniformly processed high-throughput RNA-sequencing data from multiple human populations with high-quality genome sequences. We discover extremely widespread genetic variation affecting the regulation of most genes, with transcript structure and expression level variation being equally common but genetically largely independent. Our characterization of causal regulatory variation sheds light on the cellular mechanisms of regulatory and loss-of-function variation, and allows us to infer putative causal variants for dozens of disease-associated loci. Altogether, this study provides a deep understanding of the cellular mechanisms of transcriptome variation and of the landscape of functional variants in the human genome.
AB - Genome sequencing projects are discovering millions of genetic variants in humans, and interpretation of their functional effects is essential for understanding the genetic basis of variation in human traits. Here we report sequencing and deep analysis of messenger RNA and microRNA from lymphoblastoid cell lines of 462 individuals from the 1000 Genomes Project - the first uniformly processed high-throughput RNA-sequencing data from multiple human populations with high-quality genome sequences. We discover extremely widespread genetic variation affecting the regulation of most genes, with transcript structure and expression level variation being equally common but genetically largely independent. Our characterization of causal regulatory variation sheds light on the cellular mechanisms of regulatory and loss-of-function variation, and allows us to infer putative causal variants for dozens of disease-associated loci. Altogether, this study provides a deep understanding of the cellular mechanisms of transcriptome variation and of the landscape of functional variants in the human genome.
UR - http://www.scopus.com/inward/record.url?scp=84885645853&partnerID=8YFLogxK
U2 - 10.1038/nature12531
DO - 10.1038/nature12531
M3 - Article
C2 - 24037378
AN - SCOPUS:84885645853
SN - 0028-0836
VL - 501
SP - 506
EP - 511
JO - Nature
JF - Nature
IS - 7468
ER -